Erblicher Darmkrebs (HNPCC): eine wichtige Diagnose auch im höheren Lebensalter - Kommentar

Literatur

• 1 Jass A, Stewart S M. Evolution of hereditary nonpolyposis colorectal cancer.  Gut. 1992;  33 783-786
• 2 Fitzgibbons R J, Lynch H T. Recognition and treatment of patients with hereditary non-polyposis colorectal cancer.  Ann Surg. 1987;  206 289-295
• 3 Jarvinen H J, Mecklin J P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer.  Gastroenterology. 1995;  108 1405-1411
• 4 Buhr H J, Heuschen U A, Stern J, Herfarth C. Continence preserving operation after proctocolectomy. Indications, technique and results.  Chirurg. 1993;  64 601-613
• 5 Umar A, Boland C R, Terdiman J P. et al . Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndromes) and microsatellite instability.  J of the National Cancer Institute. 2004;  18 261-268
• 6 Vasen H F, Mecklin J-P, Meera K P, Lynch H T. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC).  Dis Colon Rectum. 1991;  34 424
• 7 Vasen H F, Wijnen J T, Menko F H. et al . Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.  Gastroenterology. 1996;  110 1020-1027
• 8 Weber T. Clinical surveillance recommendations adopted for HNPCC.  Lancet. 1996;  348 465-471